1. Home
  2. SLNO vs REVG Comparison

SLNO vs REVG Comparison

Compare SLNO & REVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • REVG
  • Stock Information
  • Founded
  • SLNO 1999
  • REVG 2008
  • Country
  • SLNO United States
  • REVG United States
  • Employees
  • SLNO N/A
  • REVG N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • REVG Auto Manufacturing
  • Sector
  • SLNO Health Care
  • REVG Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • REVG Nasdaq
  • Market Cap
  • SLNO 3.8B
  • REVG 3.1B
  • IPO Year
  • SLNO 2014
  • REVG 2017
  • Fundamental
  • Price
  • SLNO $49.71
  • REVG $59.64
  • Analyst Decision
  • SLNO Strong Buy
  • REVG Hold
  • Analyst Count
  • SLNO 10
  • REVG 4
  • Target Price
  • SLNO $112.50
  • REVG $53.00
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • REVG 1.0M
  • Earning Date
  • SLNO 11-05-2025
  • REVG 09-03-2025
  • Dividend Yield
  • SLNO N/A
  • REVG 0.41%
  • EPS Growth
  • SLNO N/A
  • REVG N/A
  • EPS
  • SLNO N/A
  • REVG 2.12
  • Revenue
  • SLNO $32,656,999.00
  • REVG $2,397,000,000.00
  • Revenue This Year
  • SLNO N/A
  • REVG $3.10
  • Revenue Next Year
  • SLNO $175.39
  • REVG $7.86
  • P/E Ratio
  • SLNO N/A
  • REVG $27.94
  • Revenue Growth
  • SLNO N/A
  • REVG N/A
  • 52 Week Low
  • SLNO $41.50
  • REVG $25.76
  • 52 Week High
  • SLNO $90.32
  • REVG $64.47
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 22.26
  • REVG 59.89
  • Support Level
  • SLNO $50.63
  • REVG $61.41
  • Resistance Level
  • SLNO $72.99
  • REVG $64.47
  • Average True Range (ATR)
  • SLNO 4.32
  • REVG 2.47
  • MACD
  • SLNO -1.60
  • REVG 0.07
  • Stochastic Oscillator
  • SLNO 3.34
  • REVG 63.33

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About REVG REV Group Inc.

REV Group Inc is a United States-based designer, manufacturer, and distributor of specialty vehicles and related aftermarket parts and services. During the first fiscal quarter of 2024, the Company formed the Specialty Vehicles Segment by combining the Fire & Emergency and Commercial segment businesses. Additionally, the Recreation segment was renamed Recreational Vehicles. As a result, the Company is now organized into two reportable segments. The company operates in the United States, Canada, and the rest of the world. Maximum of revenue is gained from Specialty Vehicles Segment.

Share on Social Networks: